Moores Cancer Center at UC San Diego Health, the only NCI-designated Comprehensive Cancer Center in San Diego, is also one of only a few cancer centers in the country with the capability to explore all facets of immunotherapy, the use of drugs that stimulate the immune system to fight cancer. Our team — led by world renowned physician-scientist Ezra Cohen, MD — has activated several clinical trials to explore novel immune checkpoint inhibitors and tumor vaccines.

Videos from "Immunotherapy: Understanding the Hype and Hope"

Watch four education presentations from our recent event on the latest exciting developments in immunotherapy: 

What is Immunotherapy?

Immunotherapy is treatment that augments, retrains, or retargets the immune system to fight cancer. Your immune system consists of white blood cells, also called leukocytes, which help protect your body against infections and diseases. The goal of immunotherapy is to train these cells to attack cancer without harming healthy tissue.

The idea of immunotherapy has been around for a long time, but new developments promise to revolutionize the way we treat cancer.

Types of Immunotherapy

    Contact Our Specialists

    Clinical Trials

Spotlight on Innovation

Ezra Cohen, MD, associate director for translational science at Moores Cancer Center, and Stephen Schoenberger, PhD, professor of immunology at the La Jolla Institute for Allergy and Immunology, developed a new technology that identifies a patient’s unique targets that can be used to create a vaccine specific to each individual person.

View all immunotherapy news >

Support Our Immunotherapy Work

For information on how to support cancer immunotherapy, please call 858-246-2463.

Your support will allow us to complete our new cell processing lab more quickly and dramatically accelerate our immunotherapy trials and research, delivering this transformative therapy and its life-saving results to our patients who need help now.